Cellular level discussion of multiple sclerosis disease state — used as booth graphics for therapeutic monoclonal antibody Daclizumab (Zenapax®). Part of a series; Drug's mechanism of action graphics at cellular level for pharmaceutical project; Central nervous system; blood-brain barrier; high-affinity IL-2 receptor; T-cell activation; pathophysiology
Keywords: Advertising / Marketing, Cell biology / Histology, Disease Management, Endocrinology / Metabolic, General Medicine, Genetics, Molecular Biology, Neuroscience, Pharmacology, Virology
© Mica Duran
